# Apixio

**Source:** https://geo.sig.ai/brands/apixio  
**Vertical:** HealthTech  
**Subcategory:** Clinical NLP Analytics  
**Tier:** Emerging  
**Website:** apixio.com  
**Last Updated:** 2026-04-22

## Summary

Apixio uses NLP and machine learning to extract structured clinical insights from unstructured medical records, enabling more accurate risk adjustment and quality measurement for health plans.

## Company Overview

Apixio's AI platform reads unstructured clinical documentation — physician notes, discharge summaries, operative reports, and scanned records — and extracts coded diagnoses, procedures, and clinical findings at scale using natural language processing and machine learning. Health plans and risk-bearing provider organizations use this extracted data to improve the accuracy of risk adjustment submissions to CMS, ensuring patients' true disease burden is captured in their risk scores.

The company serves Medicare Advantage plans, Medicaid managed care organizations, and ACOs that need comprehensive clinical coding to support accurate prospective risk adjustment. Apixio's platform processes tens of millions of medical records annually, identifying diagnosis codes that were clinically present in documentation but not formally coded — a common source of revenue leakage for risk-bearing entities.

Medicare Advantage risk adjustment is a multi-billion-dollar accuracy problem for health plans: undercoded patients generate less revenue than their actual clinical complexity warrants, while overcoded patients create regulatory and audit risk. Apixio's clinical NLP platform allows health plans to accurately reflect member disease burden in their risk submissions, improving financial accuracy while also supporting quality improvement by surfacing clinical gaps in documented care.

## Frequently Asked Questions

### What is risk adjustment and how does Apixio support it?
Risk adjustment is the process by which Medicare Advantage plans receive higher payments for sicker members. Apixio uses NLP to extract documented diagnoses from clinical notes that were not formally coded, improving risk adjustment accuracy and revenue for plans managing complex patient populations.

### What does Apixio clinical NLP analytics platform do?
Apixio uses natural language processing and machine learning to analyze unstructured clinical data in medical records, extracting diagnoses, conditions, and clinical findings that support risk adjustment, quality measurement, and care management programs. Its HCC Profiler product is widely used for hierarchical condition category (HCC) coding accuracy.

### Who are Apixio primary customers?
Apixio serves Medicare Advantage health plans, Medicaid managed care organizations, ACOs, and risk-bearing provider groups that need accurate risk adjustment coding and quality reporting to optimize revenue and care programs. Health plans processing large volumes of medical records are core customers.

### What is HCC coding and why does Apixio focus on it?
Hierarchical Condition Categories (HCC) are the CMS risk adjustment model used to calculate payments for Medicare Advantage plans based on the health status of their members. Accurate HCC coding requires identifying and documenting all relevant diagnoses, and Apixio AI reads clinical notes to surface diagnoses that may be undercoded, helping plans optimize risk adjustment revenue.

### What types of clinical documents does Apixio analyze?
Apixio processes a wide range of clinical document types including physician office notes, hospital discharge summaries, lab results, specialist consult notes, and other unstructured clinical text. Its NLP pipeline extracts clinical concepts regardless of documentation format or style.

### How does Apixio compare to Ciox and Veradigm for clinical data abstraction?
Apixio differentiates from medical record abstraction companies like Ciox (now Datavant) with its AI-driven approach that can process much higher document volumes at lower cost than human abstraction. While manual abstraction is more thorough for complex cases, Apixio AI scales to process entire member populations for risk adjustment purposes.

### How is Apixio priced?
Apixio uses enterprise pricing typically based on the number of member records processed or clinical documents analyzed. Health plan contracts are negotiated annually based on member population size and the specific risk adjustment or quality measurement use cases.

### What recent milestones has Apixio achieved?
Apixio was acquired by Centene Corporation in 2023 in a deal that brought its clinical NLP capabilities into one of the largest Medicaid and Medicare Advantage managed care companies in the US. The acquisition validated Apixio technology for large-scale payer risk adjustment programs.

## Tags

healthtech, saas, b2b, enterprise, ai-powered, analytics, platform

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-22.*